Chagas Disease Cardiomyopathy: Immunopathology and Genetics
Chagas disease, caused by the protozoan Trypanosoma cruzi, is endemic in Latin America and affects ca. 10 million people worldwide. About 30% of Chagas disease patients develop chronic Chagas disease cardiomyopathy (CCC), a particularly lethal inflammatory cardiomyopathy that occurs decades after th...
Saved in:
Main Authors: | Edecio Cunha-Neto, Christophe Chevillard |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2014-01-01
|
Series: | Mediators of Inflammation |
Online Access: | http://dx.doi.org/10.1155/2014/683230 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Contemporary Management of Patients With Chagas Cardiomyopathy in Bolivia
by: Evan Czulada, BS, et al.
Published: (2025-03-01) -
Immunology and Infection by Protozoan Parasites
by: Edecio Cunha-Neto, et al.
Published: (2015-01-01) -
Myocardial Gene Expression of T-bet, GATA-3, Ror-γt, FoxP3, and Hallmark Cytokines in Chronic Chagas Disease Cardiomyopathy: An Essentially Unopposed TH1-Type Response
by: Luciana Gabriel Nogueira, et al.
Published: (2014-01-01) -
Immunopathology of Airway Surface Liquid Dehydration Disease
by: Brandon W. Lewis, et al.
Published: (2019-01-01) -
Prognostic Significance of Chronic Kidney Disease (CKD-EPI Equation) and Anemia in Patients with Chronic Heart Failure Secondary to Chagas Cardiomyopathy
by: Marcelo Arruda Nakazone, et al.
Published: (2020-01-01)